Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

MedicalPhant

Financiado

Cerrado

An advanced 3D simulator to generate 3D personalized tissue and organ models for...

An advanced 3D simulator to generate 3D personalized tissue and organ models for diagnosis planning and pre treatment of medical vascular interventions VALIDA INNOVATION S.L. emerged with the goal of developing a new 3D simulator that improves the diagnosis, planning and pre-treatment interventions and therefore, improving patient safety and reduction of associated cost to medica... ver más

30/09/2018

VALIDA INNOVATION...

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

VALIDA INNOVATION SOCIEDAD LIMITADA. Articulo 2. objeto. la sociedad tendrá por objeto las siguientes actividades: 1. prestación de toda clase de servicios de estrategia empresa...

TRL 7-8 | 50K€

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2018-09-30

EIC-SMEInst-2018-2020: SME instrument

I+D

Cerrada hace 7 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

VALIDA INNOVATION SOCIEDAD L...

50.00K€ | Lider

TOLL MANUFACTURING SERVICES...

840.66K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

INTEG-CV-SIM An Integrated Computer Modelling Framework for Subject Speci... 1M€ Cerrado

SimCardioTest Simulation of Cardiac Devices Drugs for in silico Testing... 8M€ Cerrado

VHEART VIRTUAL HEART MODELS MULTI PHYSICS APPROACHES TO COMPUTATIO... 100K€ Cerrado

PIC Personalised In Silico Cardiology 4M€ Cerrado

RAINBOW Rapid Biomechanics Simulation for Personalized Clinical Desi... 4M€ Cerrado

TIN2009-13981 IMAGENES COMPUTACIONALES DE FISIOLOGIA HUMANA PARA UNA MEDIC... 12K€ Cerrado

Duración del proyecto: 4 meses Fecha Inicio: 2018-05-04
Fecha Fin: 2018-09-30

Líder del proyecto

VALIDA INNOVATION SOCIEDAD LIMITADA. Articulo 2. objeto. la sociedad tendrá por objeto las siguientes actividades: 1. prestación de toda clase de servicios de estrategia empresa...

TRL 7-8 | 50K€

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto VALIDA INNOVATION S.L. emerged with the goal of developing a new 3D simulator that improves the diagnosis, planning and pre-treatment interventions and therefore, improving patient safety and reduction of associated cost to medical errors. This simulator provides a high value in 3D organ models due to its physical mechanical identical to the real ones are able to replicate the patient´s own organ and pathology. The main objective of MedicalPhant project is to develop and commercialized, based on MRI, ECO and CAT studies on patients, a cardiovascular personalized model of external and internal vasculature that allows simulating complex clinical situations due to cardiovascular diseases are the main cause of death globally. Currently, the simulator prototype has a technology level TRL6 and it has been validated in a relevant environment through its implementation in a real case study of cardiovascular surgery providing diagnostic capacity before intervention and patient´s safety after intervention. However, the company needs to work in the implementation of the business model, in the industrial adaptation of our prototype and, in achieving the certification of our 3D simulator to be commercialized. The key stakeholders involved in this project will be hospitals to carry out clinical trials, private, public hospitals and universities to use our technology, specialized organizations in charge of certificating our device to obtain the CE Mark and FDA, key opinion leaders to get a better penetration on the market and patient associations which will contribute to the dissemination of our innovative 3D printing technology in the cardiovascular market. The initial plan to commercialize the MedicalPhant consists in the combination of own production with a partner plus licensing of the technology. According to our estimation, the cumulative cash flow projected by VALIDA INNOVATION at year 5 will amount €10.3M meaning a ROI of 2.6%.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores